We invite you to the attend the Pan-Omics Summit, which will take place May 21 - 22, 2015 in Boston, MA at the Hyatt Regency. This summit has four parallel tracks to discuss the developments and challenges in the popular omics areas of epigenomics, metabolomics, functional genomics, and next generation sequencing. Representatives from big pharma, academic institutions, and government research labs will present data on advances in new technology and case studies on therapeutic targets, molecular diagnostics, and integration of complex data.
The Pan-Omics Summit is comprised of 4 parallel conferences:
I. Current and Emerging Sequencing Technologies II. Metagenomics and the Microbiome III. Leveraging Big Data for Biomedical Discoveries and Applications IV. Clinical Diagnostic Sequencing V. RNA Sequencing VI. Single Cell Genomics VII. How Information and Technology get into the Clinic
I. Advances in Metabolite Markers II. Metabolite Identification - Targets and Pathways III. Computational Approaches to Assessing the Metabolome IV. Technological Advances in Metabolomics V. Clinical Applications of Metabolomics
I. Transcriptional Regulation II. Novel Therapeutic Targets and Discovery III. Pre-Clinical to Clinical Drug Development IV. New Technological Advances V. Epigenomic Biomarkers and Diagnostics VI. Neurological Disorders and Other Diseases
I. Genomic Variation as a Predictor of Protein-protein and Protein Drug Interactions II. Molecular Diagnostics & Therapeutic Applications for Complex Diseases III. Transcriptome Profiling and Genome Regulation by mRNAs, microRNAs and long noncoding RNAs IV. Approaches for Analysis and Integration of Complex Data V. Genome Wide Mutagenesis and Phenotypic Analysis VI. Challenges in Target Validation VII. Prospects for Epigenomic-based Drug Discovery
